Previous 10 | Next 10 |
2023-06-23 09:50:46 ET Barclays downgraded Viatris Inc. ( NASDAQ: VTRS ) to Underweight from Equal Weight on Friday, noting that despite its low valuation, the generic drugmaker will likely remain a "show-me narrative" until there is clarity on its future strategy. The analyst B...
2023-06-20 05:53:32 ET Summary Viatris, a healthcare company, faces weakening fundamentals and significant risks, including uncertainty regarding its execution plan. Despite these challenges, the company has growth opportunities, with over $3 billion in annual sales expected to ma...
2023-06-15 12:37:07 ET Summary Viatris remains a dirt cheap stock in a frothy market and pays a well-covered dividend yield. It continues to make progress towards deleveraging, and could return substantial capital to shareholders in 2024. With market sentiment working against ...
2023-06-13 18:36:06 ET Viatris Inc. (VTRS) Goldman Sachs 44th Annual Global Healthcare Conference June 13, 2023, 04:20 PM ET Company Participants Scott Smith - CEO Rajiv Malik - President Sanjeev Narula - CFO Conference Call Participants Nathan Rich -...
2023-06-08 08:08:00 ET You can secure a 5% dividend yield without being too risky or aggressive. Sometimes, it's a matter of jumping on a good opportunity when it arises. A stock can fall in value for various reasons, including a general bear market, and that pushes its yield up. As long as...
2023-06-07 07:00:00 ET Summary Markets overreacted to Norwich suing the FDA. Investors must consider recently reported weak Q1 results of Bausch Health. Reasons BHC stock is a buy from here. Last summer, Bausch Health ( BHC ) traded with wild 11% drops . Vola...
Viatris Named to USA Today's Inaugural List of America's Climate Leaders 2023 PR Newswire PITTSBURGH , May 30, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that it has been named to USA Today's ina...
2023-05-22 12:01:10 ET Viatris ( NASDAQ: VTRS ) has declared $0.12/share quarterly dividend , in line with previous. Payable June 16; for shareholders of record May 24; ex-div May 23. See VTRS Dividend Scorecard, Yield Chart, & Dividend Growth. For furthe...
Robert J. Coury to Transition from Executive Chairman of Viatris to Chairman Emeritus and Senior Strategic Advisor to the Board and Management at the End of the Year PR Newswire Coury will serve in this new role until the end of 2025 PITTSBURGH , May 22, 2023...
Viatris Announces Appointment of Leo Groothuis to Company's Board of Directors PR Newswire PITTSBURGH , May 22, 2023 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, today announced that as part of its ongoing board refreshment effort...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 12:25:00 ET The late comedian Rodney Dangerfield was famous for his catchphrase, "I don't get no respect." Does Dangerfield's line apply to some stocks today? Absolutely. Three Motley Fool contributors think they've found surprisingly underrated pharmaceutical stocks to b...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...